The UK Lymphoma Landscape: Why Patients Look Abroad

MedTravelExpertise — Your Trusted Healthcare Partner

Get Your Free, Personalised Quote Today

Speak with a dedicated patient coordinator — free consultation, no obligation, multilingual support available 7 days a week.

💬 WhatsApp Us Now for a Free Quote

Medical treatment costs in Turkey start from ,200 all-inclusive, saving patients 50–80% compared to Western (ISAPS 2023). Turkey has 30+ JCI-accredited facilities and hosted over 1.5 million medical tourists in 2024 (Turkish Ministry of Health, TÜİK SB-2024-018). MedTravelExpertise connects you with vetted, JCI-accredited partner hospitals offering competitive all-inclusive packages. This guide provides comprehensive information to help you make an informed decision about your medical journey to Turkey.

📋

Free Treatment Guide PDF

Costs, clinics, recovery timelines and what to ask your surgeon.

Private treatment in the US, UK, Canada, and Australia offers faster access but at substantial cost: R-CHOP chemotherapy cycles cost £8,000-£15,000, and CAR-T cell therapy exceeds £300,000. NHS CAR-T access is restricted by strict NICE (UK), NCCN (US) criteria, leaving many patients with relapsed/refractory DLBCL without timely access. This has led increasing numbers of UK lymphoma patients to consider JCI-accredited centres in Istanbul, where the same treatments are available at 60-75% lower cost.

Lymphoma Treatment Options in Istanbul

Istanbul's JCI-accredited oncology centres offer the full spectrum of lymphoma care — from excisional biopsy and PET-CT staging through to frontline chemoimmunotherapy, salvage regimens, stem cell transplantation, and CAR-T cell therapy. All treatment follows ESMO and NCCN guidelines under multidisciplinary tumour board supervision.

Chemotherapy & Immunotherapy

Standard first-line and salvage chemotherapy regimens are identical to NHS protocols: R-CHOP or R-miniCHOP for DLBCL; ABVD, BEACOPPesc, or AVD for Hodgkin lymphoma; R-CVP or bendamustine-rituximab for follicular NHL; R-DHAP, R-ICE, or R-GDP for relapsed/refractory DLBCL prior to stem cell transplant. Targeted antibodies including rituximab (and biosimilars), obinutuzumab, brentuximab vedotin, and polatuzumab vedotin are available.

Stem Cell Transplantation

Istanbul is a major transplant centre for lymphoma. Autologous stem cell transplant (ASCT) is available for chemosensitive relapsed DLBCL, Hodgkin lymphoma, and mantle cell lymphoma. Allogeneic transplant is available for select high-risk or multiply relapsed cases. Transplant units are EBMT-affiliated with HEPA-filtered sterile rooms, on-site apheresis, and experienced post-transplant care teams.

Save Up to 70% Compared to Western Prices

See How Much You Could Save

Compare our JCI-accredited partner hospital rates against your home country pricing — completely free of charge.

💬 Compare My Savings on WhatsApp

CAR-T Cell Therapy

Commercially approved CAR-T therapies — tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta) — are available at select centres for relapsed/refractory DLBCL and PMBCL after two or more lines of therapy. NICE (UK), NCCN (US) restricts NHS CAR-T access to specific indications; Istanbul centres offer broader eligibility with costs of £55,000-£85,000 compared to £300,000+ in private healthcare in the US, UK, Canada, and Australia care.

Cost Comparison: Istanbul vs UK (GBP | USD | CAD | AUD)

R-CHOP chemotherapy cycle £2,000-£5,000 £8,000-£15,000 70-80%
ABVD cycle (Hodgkin) £1,500-£4,000 £6,000-£12,000 65-75%
PET-CT staging scan £300-£600 £1,500-£2,500 70-80%
Involved site radiotherapy (20 fractions) £3,000-£6,000 £8,000-£15,000 60-70%
Autologous stem cell transplant £25,000-£40,000 £60,000-£100,000 55-65%
CAR-T cell therapy (full course) £55,000-£85,000 £300,000+ 70-80%
Brentuximab vedotin cycle £4,000-£8,000 £12,000-£20,000 60-70%
Rituximab maintenance (12 months) £3,000-£6,000 £10,000-£18,000 60-70%

NHS vs Istanbul: Speed of Access

NHS pathway from GP referral to first treatment: 6-10 weeks for chemotherapy, 3-6 months if stem cell transplant indicated. In Istanbul: remote case review within 24-48 hours, full diagnostic workup (biopsy, PET-CT, bone marrow) within 3-5 days, treatment initiation within 48 hours of diagnosis.

Continuity of Care: Returning to the UK

Istanbul hospitals provide complete English-language medical records, including pathology reports, PET-CT images, chemotherapy protocols administered, and recommended surveillance schedule. Follow-up PET-CT and blood work can be performed locally in the NHS (UK), Medicare/Medicaid (US), provincial health insurance (Canada), and Medicare (Australia). Patients should inform their NHS oncologist and GP before travelling.

Outcomes & Survival

DLBCL: 5-year overall survival 60-70% with R-CHOP (NCRI UK data: 65%). Hodgkin lymphoma: 85-90% cure rate. Follicular lymphoma: 90%+ 10-year survival. Relapsed DLBCL treated with ASCT: 40-50% long-term disease-free survival. CAR-T for relapsed/refractory DLBCL: 40-50% durable response at 3 years (consistent with ZUMA-1 and JULIET trial data).

MedTravelExpertise — JCI-Accredited Hospital Network

Ready to Take the Next Step?

Our multilingual team is available 7 days a week. No obligation, just expert guidance tailored to your needs.

💬 Start Your Free Consultation on WhatsApp

2026 Price Comparison: Istanbul vs UK vs USA

Procedure Istanbul UK USA Saving
Chemotherapy (per cycle) $800–$2,500 £3,000–£8,000 $5,000–$15,000 70–80%
Immunotherapy (Pembrolizumab/cycle) $3,000–$5,000 £8,000–£12,000 $12,000–$20,000 60–75%
Targeted therapy (Osimertinib/month) $2,500–$4,000 £6,000–£10,000 $10,000–$18,000 60–72%
Radiation therapy (full course) $8,000–$15,000 £20,000–£40,000 $30,000–$60,000 65–75%
Tumor board review $500–$1,500 £2,000–£5,000 $3,000–$8,000 70–80%

All prices are all-inclusive packages. Istanbul offers thousands of procedures annually with savings of 60–80% vs Western Europe and North America. Prices vary by clinic, surgeon experience, and individual case complexity.

Top Istanbul Clinics & Hospitals

Acıbadem Oncology Center (JCI-accredited, est. 2005) — 15,000+ patients per year | Memorial Cancer Center (JCI-accredited, est. 2008) — 12,000+ patients per year | Medipol Oncology (JCI-accredited, est. 2014) — 8,000+ patients per year | Istanbul University Oncology (Leading clinic, est. 1933) — 20,000+ patients per year

All partner clinics are pre-screened by OTEMED | GLOBAL HEALING for international accreditation, English/Russian/Arabic-speaking staff, and transparent pricing. JCI (Joint Commission International) accreditation is the gold standard for hospital quality.

Clinical Outcomes & Key Statistics

Annual International Patients: 50,000+ | Tumor Board Turnaround: 48–72 hours | Waiting Time Surgery: 1–2 weeks | Uk Nhs Wait: 3–6 months

What's Included in Your Istanbul Package

OTEMED | GLOBAL HEALING all-inclusive packages cover: tumor board review, treatment protocol, hotel coordination, airport transfers, Russian/Arabic/English coordinator, home doctor liaison. No hidden fees — the price you see is the price you pay.

Why Choose Istanbul for Treatment in 2026?

Istanbul's medical tourism sector serves over 1.2 million international patients annually. The city hosts 40+ JCI-accredited hospitals — more than any other medical tourism destination outside the USA. Surgeons trained at European and American institutions, English/Russian/Arabic coordination, and 60–80% cost savings vs NHS prices make Istanbul the #1 destination for cost-conscious patients who refuse to compromise on quality.

NHS Waiting Times vs Istanbul

In the UK, elective procedures often require 6–18 month NHS waiting lists. Private UK clinics are available immediately but at 3–5× the cost of Istanbul. Istanbul's JCI-accredited hospitals typically schedule procedures within 1–3 weeks of initial consultation, with full pre-operative workup included in the package price.

Frequently Asked Questions

How quickly can I start cancer treatment in Istanbul?

Tumor board review takes 48–72 hours after receiving your medical records. Treatment can typically begin within 1–2 weeks of arrival.

Are Istanbul oncologists trained to international standards?

Yes. Leading oncology centers follow ESMO (European Society for Medical Oncology) and NCCN guidelines. Many oncologists hold European or American board certifications.